Banner

Reducing the risk of bleb failure aided by CAT-152

Article

Norwich, England-A human monoclonal antibody, CAT-152, may help aid bleb survival in patients with primary open-angle glaucoma who are undergoing phacotrabeculectomy, said David C. Broadway, MD.

Related Videos
Related Content

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

Johnson & Johnson launches Vision Made Possible to prompt discussions on eye health

October 1st 2023

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

Johnson & Johnson launches Vision Made Possible to prompt discussions on eye health

October 1st 2023

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

Johnson & Johnson launches Vision Made Possible to prompt discussions on eye health

October 1st 2023
© 2023 MJH Life Sciences

All rights reserved.